InMode stock carries a Hold consensus before Q3 results
Published on 10/06/2026 at 13:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSInMode Ltd. (ISIN IL0011595993) was last at USD 14.13 on Nasdaq on October 5, 2026, while seven analysts assigned the company a Hold consensus and a USD 16.00 average target. The next earnings date gives the market a concrete checkpoint, with Q3 results scheduled for October 28, 2026.
Seven analysts set a USD 16.00 target
According to MarketBeat on October 5, 2026, five of the seven analysts rated InMode Hold, while one issued a Buy rating and one issued a Sell rating. The USD 16.00 average target lies 13.2 percent above the USD 14.13 price, making the consensus a measurable upside reference rather than a uniform bullish call.
The latest quarterly comparison is more restrained. MarketBeat reported that InMode's Q2 2026 adjusted EPS was USD 0.35, matching consensus, while revenue reached USD 95.59 million against a USD 94.89 million estimate.
Q2 revenue holds at USD 95.59 million
PR Newswire reported on August 5, 2026, that InMode's Q2 GAAP revenue was USD 95.6 million, consistent with Q2 2025. That flat comparison puts greater emphasis on the coming quarter's sales mix and the company's ability to convert stable revenue into earnings growth.
InMode develops energy-based medical technology for aesthetic and medical treatments, including platforms sold under the Morpheus8, BodyTite, FaceTite, Forma and Lumecca brands. The business therefore combines capital equipment sales with recurring treatment-related demand, a distinction that makes revenue quality relevant alongside the headline total.
Q3 results arrive October 28
MarketBeat lists October 28, 2026, as the Q3 reporting date before the market opens and shows consensus EPS of USD 0.32 and expected revenue of USD 91.59 million. Those estimates sit below the USD 95.59 million reported for Q2, giving the upcoming release a clear numerical comparison.
InMode stock was last at USD 14.13
InMode stock was last at USD 14.13 on Nasdaq on October 5, 2026, with a daily gain of 0.28 percent. The USD 812.2 million market capitalization, 464,635-share volume and USD 12.72 to USD 16.74 52-week range frame the valuation ahead of the October report.
InMode stock at a glance
- Company: InMode Ltd.
- ISIN: IL0011595993
- Ticker: INMD
- Trading venue: Nasdaq
- Price (as of October 5, 2026, 4:00 p.m. ET): USD 14.13
- Market capitalization: USD 812.2 million (as of October 5, 2026)
- 52-week range: USD 12.72-16.74 (as of October 5, 2026)
- Sector / Industry: Health Care / Medical Technology
Upcoming dates for InMode stock
- October 28, 2026: Q3 2026 results before the market opens
